These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26547601)

  • 1. HPV9: Combating HPV-associated cancers by strengthening serotype defenses.
    Dougherty SA; Hayney MS
    J Am Pharm Assoc (2003); 2015; 55(6):670-672. PubMed ID: 26547601
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9-14 years: Results to month 12 from a randomized trial.
    Leung TF; Liu AP; Lim FS; Thollot F; Oh HM; Lee BW; Rombo L; Tan NC; Rouzier R; Friel D; De Muynck B; De Simoni S; Suryakiran P; Hezareh M; Folschweiller N; Thomas F; Struyf F
    Hum Vaccin Immunother; 2015; 11(7):1689-702. PubMed ID: 26062002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diseases caused by human papillomavirus -- the possibilities and the public health advantages of prevention].
    Acs N; Bata Z; Danko D; Hernádi Z; Kálmán M; Kornya L; Kovács J; Mézáros G; Molnár MP; Mór Z; Novák Z; Sobel G; Szentirmay Z; Takács L; Tisza T
    Orv Hetil; 2012 Dec; 153 Suppl():3-38. PubMed ID: 23687666
    [No Abstract]   [Full Text] [Related]  

  • 4. [HPV vaccination].
    Stronski Huwiler S; Spaar A
    Ther Umsch; 2016; 73(5):241-6. PubMed ID: 27268446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV vaccination of immunocompromised hosts.
    Garland SM; Brotherton JML; Moscicki AB; Kaufmann AM; Stanley M; Bhatla N; Sankaranarayanan R; de Sanjosé S; Palefsky JM;
    Papillomavirus Res; 2017 Dec; 4():35-38. PubMed ID: 29179867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of a large outcome trial for a multivalent human papillomavirus L1 virus-like particle vaccine.
    Luxembourg A; Bautista O; Moeller E; Ritter M; Chen J
    Contemp Clin Trials; 2015 May; 42():18-25. PubMed ID: 25749310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and persistence of immunity of a quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children.
    MacIntyre CR; Shaw P; Mackie FE; Boros C; Marshall H; Barnes M; Seale H; Kennedy SE; Moa A; Hayen A; Chughtai AA; O'Loughlin EV; Stormon M
    Vaccine; 2016 Aug; 34(36):4343-50. PubMed ID: 27406936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gardasil 9--a broader HPV vaccine.
    Med Lett Drugs Ther; 2015 Mar; 57(1465):47-8. PubMed ID: 25853579
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of safety and immunogenicity of a quadrivalent human papillomavirus vaccine in healthy females between 9 and 26 years of age in Sub-Saharan Africa.
    Mugo N; Ansah NA; Marino D; Saah A; Garner EI
    Hum Vaccin Immunother; 2015; 11(6):1323-30. PubMed ID: 25912475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV 6, 11, 16, 18 vaccine in men. Inadequate assessment.
    Prescrire Int; 2012 Sep; 21(130):208. PubMed ID: 23016251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Pappilomavirus (HPV) induced cancers and prevention by immunization.
    Khaliq SA; Shyum Naqvi SB; Fatima A
    Pak J Pharm Sci; 2012 Oct; 25(4):763-72. PubMed ID: 23009992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of human papillomavirus vaccines: a review.
    Stillo M; Carrillo Santisteve P; Lopalco PL
    Expert Opin Drug Saf; 2015 May; 14(5):697-712. PubMed ID: 25689872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-dose schedule for human papillomavirus vaccine.
    Baker H
    Lancet Oncol; 2017 Jan; 18(1):e3. PubMed ID: 27916396
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines.
    Van Damme P; Bonanni P; Bosch FX; Joura E; Kjaer SK; Meijer CJ; Petry KU; Soubeyrand B; Verstraeten T; Stanley M
    Vaccine; 2016 Feb; 34(6):757-61. PubMed ID: 26772631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A delayed dose of quadrivalent human papillomavirus vaccine demonstrates immune memory in HIV-1-infected men.
    Ellsworth GB; Lensing SY; Ogilvie CB; Lee JY; Goldstone SE; Berry-Lawhorn JM; Jay N; Stier EA; Logan JS; Einstein MH; Saah A; Mitsuyasu RT; Aboulafia D; Palefsky JM; Wilkin TJ
    Papillomavirus Res; 2018 Dec; 6():11-14. PubMed ID: 29807211
    [No Abstract]   [Full Text] [Related]  

  • 16. Second-generation prophylactic HPV vaccines: current options and future strategies for vaccines development.
    Fruscalzo A; Londero AP; Bertozzi S; Lellè RJ
    Minerva Med; 2016 Feb; 107(1):26-38. PubMed ID: 26473283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
    Dunne EF; Datta SD; E Markowitz L
    Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination for the prevention of human papillomavirus cancers.
    CA Cancer J Clin; 2020 Jul; 70(4):281-282. PubMed ID: 32639021
    [No Abstract]   [Full Text] [Related]  

  • 19. Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists.
    McIntosh J; Sturpe DA; Khanna N
    J Am Pharm Assoc (2003); 2008; 48(1):e1-13; quiz e14-7. PubMed ID: 18192123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
    Muñoz N; Manalastas R; Pitisuttithum P; Tresukosol D; Monsonego J; Ault K; Clavel C; Luna J; Myers E; Hood S; Bautista O; Bryan J; Taddeo FJ; Esser MT; Vuocolo S; Haupt RM; Barr E; Saah A
    Lancet; 2009 Jun; 373(9679):1949-57. PubMed ID: 19493565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.